BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 27743302)

  • 1. Effect of lifestyle interventions with or without metformin therapy on serum levels of osteoprotegerin and receptor activator of nuclear factor kappa B ligand in patients with prediabetes.
    Arslan MS; Tutal E; Sahin M; Karakose M; Ucan B; Ozturk G; Cakal E; Biyikli Gencturk Z; Ozbek M; Delibasi T
    Endocrine; 2017 Feb; 55(2):410-415. PubMed ID: 27743302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects.
    Ashley DT; O'Sullivan EP; Davenport C; Devlin N; Crowley RK; McCaffrey N; Moyna NM; Smith D; O'Gorman DJ
    Metabolism; 2011 Jul; 60(7):994-1000. PubMed ID: 21087777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A refined-JinQi-JiangTang tablet ameliorates prediabetes by reducing insulin resistance and improving beta cell function in mice.
    Gao LH; Liu Q; Liu SN; Chen ZY; Li CN; Lei L; Sun SJ; Li LY; Liu JL; Shen ZF
    J Ethnopharmacol; 2014; 151(1):675-85. PubMed ID: 24286962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction.
    Pepene CE; Ilie IR; Marian I; Duncea I
    Eur J Endocrinol; 2011 Jan; 164(1):61-8. PubMed ID: 20974706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation between osteoprotegerin, inflammatory processes, and atherosclerosis in patients with metabolic syndrome.
    Musialik K; Szulińska M; Hen K; Skrypnik D; Bogdański P
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4379-4385. PubMed ID: 29077157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk factors, carotid artery intima media thickness, and HSCRP levels in patients with impaired glucose metabolism.
    Karbek B; Cakal E; Cakir E; Bozkurt N; Unsal I; Sahin M; Delibaşi T
    Minerva Endocrinol; 2013 Sep; 38(3):297-304. PubMed ID: 24126550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of the osteopontin-osteocalcin-osteoprotegerin triad in the pathogenesis of prediabetes in humans.
    Daniele G; Winnier D; Mari A; Bruder J; Fourcaudot M; Pengou Z; Hansis-Diarte A; Jenkinson C; Tripathy D; Folli F
    Acta Diabetol; 2018 Feb; 55(2):139-148. PubMed ID: 29151224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of prediabetes in clinical practice: targeting insulin resistance and β-cell dysfunction.
    Armato J; DeFronzo RA; Abdul-Ghani M; Ruby R
    Endocr Pract; 2012; 18(3):342-50. PubMed ID: 22068250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Metformin on Anthropometric Measurements and Hormonal and Biochemical Profile in Patients with Prediabetes.
    Safiah M; Hyassat D; Khader Y; Farahid O; Batieha A; El-Khateeb M; Ajlouni K
    J Diabetes Res; 2021; 2021():8275303. PubMed ID: 34950736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rationale, design, and baseline characteristics of PREVENT-DM: A community-based comparative effectiveness trial of lifestyle intervention and metformin among Latinas with prediabetes.
    Perez A; Alos VA; Scanlan A; Maia CM; Davey A; Whitaker RC; Foster GD; Ackermann RT; O'Brien MJ
    Contemp Clin Trials; 2015 Nov; 45(Pt B):320-327. PubMed ID: 26597415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meal replacement regimen improves blood glucose levels in prediabetic healthy individuals with impaired fasting glucose.
    König D; Kookhan S; Schaffner D; Deibert P; Berg A
    Nutrition; 2014; 30(11-12):1306-9. PubMed ID: 25194963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.
    Worsley R; Jane F; Robinson PJ; Bell RJ; Davis SR
    Climacteric; 2015 Apr; 18(2):270-7. PubMed ID: 25333776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin treatment to reduce central adiposity after prenatal growth restraint: a placebo-controlled pilot study in prepubertal children.
    Díaz M; Bassols J; López-Bermejo A; de Zegher F; Ibáñez L
    Pediatr Diabetes; 2015 Nov; 16(7):538-45. PubMed ID: 25332100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
    Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Obex in Overweight and Obese Subjects With or Without Impaired Fasting Glucose: A Pilot Study.
    Cabrera-Rode E; Rodríguez J; Álvarez A; Echevarría R; Reyes AD; Cubas-Dueñas I; Turcios-Tristá SE; Díaz-Díaz O
    J Diet Suppl; 2017 Nov; 14(6):626-639. PubMed ID: 28384000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus.
    Park JS; Cho MH; Nam JS; Yoo JS; Ahn CW; Cha BS; Kim KR; Lee HC
    Eur J Endocrinol; 2011 Jan; 164(1):69-74. PubMed ID: 20961967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention.
    Fu JF; Liang L; Zou CC; Hong F; Wang CL; Wang XM; Zhao ZY
    Int J Obes (Lond); 2007 Jan; 31(1):15-22. PubMed ID: 16953257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of saxagliptin on glucose homeostasis and body composition of obese patients with newly diagnosed pre-diabetes.
    Wang Z; Xu D; Huang L; Zhang T; Wang J; Chen Q; Kong L; Zhou X
    Diabetes Res Clin Pract; 2017 Aug; 130():77-85. PubMed ID: 28575729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediabetes in patients treated with antipsychotic drugs.
    Manu P; Correll CU; van Winkel R; Wampers M; De Hert M
    J Clin Psychiatry; 2012 Apr; 73(4):460-6. PubMed ID: 22225552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
    Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
    J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.